跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION
Approved
STANDARD
CITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION
Pfizer S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 29, 2021
Approval ID
08aa56e2e032637d
Company
Pfizer S.L.
Type
Standard
Approval Details
Approval Id
08aa56e2e032637d
Drug Cima Aemps Name
CITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION
Register Number
86180
Holder Company Name
Pfizer S.L.
Marketing Company Name
Pfizer S.L.
Authorization Date
2021-08-29
Dosage Form
SOLUCION INYECTABLE Y PARA PERFUSION
Dose
20 mg/ml
Route Of Administration
VÍA INTRATECAL, VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Pfizer S.L.
Active Ingredients
CITARABINA
20 mg/ml mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 29, 2021
Approval ID
08aa56e2e032637d
Type
Standard
Back to CIMA-AEMPS Approvals